149 related articles for article (PubMed ID: 17242154)
1. Lack of relationship between purine biosynthesis and vancomycin resistance in Staphylococcus aureus: a cautionary tale for microarray interpretation.
Fox PM; Climo MW; Archer GL
Antimicrob Agents Chemother; 2007 Apr; 51(4):1274-80. PubMed ID: 17242154
[TBL] [Abstract][Full Text] [Related]
2. Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin.
Mongodin E; Finan J; Climo MW; Rosato A; Gill S; Archer GL
J Bacteriol; 2003 Aug; 185(15):4638-43. PubMed ID: 12867477
[TBL] [Abstract][Full Text] [Related]
3. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
[TBL] [Abstract][Full Text] [Related]
4. The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
Xiong YQ; Li Y; Goncheva MI; Elsayed AM; Zhu F; Li L; Abdelhady W; Flannagan RS; Yeaman MR; Bayer AS; Heinrichs DE
J Infect Dis; 2024 Jun; 229(6):1648-1657. PubMed ID: 38297970
[TBL] [Abstract][Full Text] [Related]
5.
Goncheva MI; Flannagan RS; Heinrichs DE
Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32094249
[No Abstract] [Full Text] [Related]
6. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
[TBL] [Abstract][Full Text] [Related]
7. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Neoh HM; Cui L; Yuzawa H; Takeuchi F; Matsuo M; Hiramatsu K
Antimicrob Agents Chemother; 2008 Jan; 52(1):45-53. PubMed ID: 17954695
[TBL] [Abstract][Full Text] [Related]
8. A transcriptional activator, homologous to the Bacillus subtilis PurR repressor, is required for expression of purine biosynthetic genes in Lactococcus lactis.
Kilstrup M; Martinussen J
J Bacteriol; 1998 Aug; 180(15):3907-16. PubMed ID: 9683488
[TBL] [Abstract][Full Text] [Related]
9. Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS.
Berscheid A; François P; Strittmatter A; Gottschalk G; Schrenzel J; Sass P; Bierbaum G
J Antimicrob Chemother; 2014 Dec; 69(12):3190-8. PubMed ID: 25103491
[TBL] [Abstract][Full Text] [Related]
10. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
Shoji M; Cui L; Iizuka R; Komoto A; Neoh HM; Watanabe Y; Hishinuma T; Hiramatsu K
Antimicrob Agents Chemother; 2011 Aug; 55(8):3870-81. PubMed ID: 21628539
[TBL] [Abstract][Full Text] [Related]
11. The purine biosynthesis regulator PurR moonlights as a virulence regulator in
Sause WE; Balasubramanian D; Irnov I; Copin R; Sullivan MJ; Sommerfield A; Chan R; Dhabaria A; Askenazi M; Ueberheide B; Shopsin B; van Bakel H; Torres VJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13563-13572. PubMed ID: 31217288
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance.
Chen H; Xiong Z; Liu K; Li S; Wang R; Wang X; Zhang Y; Wang H
Int J Antimicrob Agents; 2016 May; 47(5):362-7. PubMed ID: 27084050
[TBL] [Abstract][Full Text] [Related]
13. Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus.
Tan XE; Neoh HM; Looi ML; Chin SF; Cui L; Hiramatsu K; Hussin S; Jamal R
Can J Microbiol; 2017 Mar; 63(3):260-264. PubMed ID: 28059579
[TBL] [Abstract][Full Text] [Related]
14. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
[TBL] [Abstract][Full Text] [Related]
15. WalK(S221P), a naturally occurring mutation, confers vancomycin resistance in VISA strain XN108.
Peng H; Hu Q; Shang W; Yuan J; Zhang X; Liu H; Zheng Y; Hu Z; Yang Y; Tan L; Li S; Hu X; Li M; Rao X
J Antimicrob Chemother; 2017 Apr; 72(4):1006-1013. PubMed ID: 27999059
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.
Gardner SG; Marshall DD; Daum RS; Powers R; Somerville GA
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109158
[No Abstract] [Full Text] [Related]
17. sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.
Lamichhane-Khadka R; Cantore SA; Riordan JT; Delgado A; Norman AE; Dueñas S; Zaman S; Horan S; Wilkinson BJ; Gustafson JE
Int J Antimicrob Agents; 2009 Aug; 34(2):136-41. PubMed ID: 19324528
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.
Pieper R; Gatlin-Bunai CL; Mongodin EF; Parmar PP; Huang ST; Clark DJ; Fleischmann RD; Gill SR; Peterson SN
Proteomics; 2006 Aug; 6(15):4246-58. PubMed ID: 16826566
[TBL] [Abstract][Full Text] [Related]
19. Strain dependence of the cell wall-damage induced stimulon in Staphylococcus aureus.
McCallum N; Spehar G; Bischoff M; Berger-Bächi B
Biochim Biophys Acta; 2006 Oct; 1760(10):1475-81. PubMed ID: 16891058
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains.
Drummelsmith J; Winstall E; Bergeron MG; Poirier GG; Ouellette M
J Proteome Res; 2007 Dec; 6(12):4690-702. PubMed ID: 17997515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
